All News

In recent interviews, Rajesh Bhayana, M.D., Manisha Bahl, M.D., and Jeremie Calais, M.D., Ph.D., shared their thoughts on agentic AI, key directions in breast imaging research and emerging trends with prostate cancer theranostics in 2026.

Geared toward facilitating earlier detection and efficiencies in emergency department workflow, the AI triage software reportedly has 11 newly cleared indications.

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

In a recent interview, Manisha Bahl, M.D., discussed recent research demonstrating a significant decline in the sensitivity of digital breast tomosynthesis (DBT) with increasing breast density as well as challenges in the utilization of supplemental imaging for women with dense breasts.

In a seven study meta-analysis with a total of 493 cases involving high-risk breast lesions, researchers found that contrast-enhanced breast MRI did not miss any cases of invasive breast cancer.

In a recent interview, David Yankelevitz, M.D., discussed the recent FDA clearance of the AI-CVD multisystem screening software and the ongoing evolution of incorporating computed tomography into personalized screening and risk assessments.

Incorporating AI to reduce artifacts and bolster soft tissue contrast, the Elekta Evo CT-Linac system reportedly improves detection of tumors and organs-at-risk.

While some job offers may sound very tempting, savvy radiologists ask prospective employers to show more than the money in order to assess a potential jump for a new gig.

Catch up on a variety of new FDA clearances in radiology from the past week.

Offering an echogenic cutting cannula and enhanced sampling capability, the EnCor EnCompass Breast Biopsy and Tissue Removal System reportedly enables biopsy procedures across different breast imaging platforms.

From satisfaction of search to grouped microcalcifications and challenges with isodense asymmetries and blind spots, the authors of a new review discuss contributing factors and preventive measures to avoid missed diagnoses of breast cancer in mammography interpretation.

In a recent interview, Rajesh Bhayana, M.D., discussed pertinent findings from a new study examining the use of the large language model GPT-4o in facilitating protocoling for abdominal and pelvic CT exams.

Offering a biocompatible, non-metallic alternative to metallic tumor markers, the VM1 tumor marker reportedly offers artifact-free visibility across a variety of breast imaging including mammography, ultrasound and MRI.

In what may be the largest study to assess digital breast tomosynthesis (DBT) screening of women with dense breasts, researchers noted only a 61.8 percent sensitivity for women with extremely dense breasts.

In a recent interview, Mina Makary, M.D., discussed recent research examining diversity within interventional radiology (IR), attrition rates in IR residency programs and potential strategies to bolster recruitment and retention.

After a causal mediation analysis that adjusted for breast density, researchers found that Black women had a significantly higher likelihood of high MRI-derived background parenchymal enhancement (BPE) than White women in a study involving nearly 2,500 women.

Offering compact versatility for an array of clinical settings, the ASUS Handheld Ultrasound LU800 is reportedly the first handheld device to be supported across Android, Chrome, iOS and Windows operating systems.

In a recent interview, Ron Blankstein, M.D., discussed insights from a recent consensus statement from the American College of Cardiology on AI-enabled plaque quantification with coronary computed tomography angiography (CCTA) exams, and other pertinent considerations with the emerging technology.

The AI-CVD software reportedly combines automated quantitative measurements for cardiovascular assessments such as coronary artery calcium (CAC) scoring and epicardial fat volumetry with lung attenuation and liver attenuation analysis in one CT-based AI platform.

Is the current OLA process a viable alternative for assessing our skills?

Catch up on the top radiology content of the past week.

The upgraded RefleXion X2 platform offers a 20 cm field of view that may bolster visualization of moving tumors.

For patients with triple-negative breast cancer being treated with neoadjuvant chemotherapy and immunotherapy, MRI demonstrated a 94.3 percent sensitivity for predicting pathologic complete response, according to a new study.

In addition to offering a variety of AI features, the Magnetom Flow 1.5T MRI system reportedly facilitates a 56 percent reduction in annual energy consumption in comparison to previous MRI scanners.

The use of contrast-enhanced mammography in nearly 200 cases of screening recalls yielded a 96.1 percent per-breast sensitivity rate and a 99 percent negative predictive value.

In a recent interview, Onofrio Catalano, M.D., Ph.D., discussed new research findings demonstrating robust sensitivity and specificity in detecting hepatocellular carcinoma in patients with LI-RADS 3 presentations.

In a study involving over 1,400 patients who had abdominal or pelvic CTs, the large language model GPT-4o selected optimal protocols in 96.2 percent of cases in comparison to 88.3 percent for radiologists.

The Echo Stewardship Program, which allows non-sonographer clinicians to perform focused cardiac ultrasound exams under physician guidance, is now cleared for use across handheld, laptop and cart-based ultrasound platforms